186 related articles for article (PubMed ID: 35501730)
1. Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia.
Wang G; Yan G; Sang K; Yang H; Sun N; Bai Y; Xu F; Zheng X; Chen Z
BMC Cancer; 2022 May; 22(1):481. PubMed ID: 35501730
[TBL] [Abstract][Full Text] [Related]
2. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
Bai Y; Chen C; Guo X; Ding T; Yang X; Yu J; Yang J; Ruan J; Zheng X; Chen Z
Cancer Biomark; 2020; 29(1):125-137. PubMed ID: 32568176
[TBL] [Abstract][Full Text] [Related]
3. Genome‑wide profiling of lncRNA expression patterns in patients with acute promyelocytic leukemia with differentiation therapy.
Yu J; Guo XL; Bai YY; Yang JJ; Zheng XQ; Ruan JC; Chen ZG
Oncol Rep; 2018 Sep; 40(3):1601-1613. PubMed ID: 29956795
[TBL] [Abstract][Full Text] [Related]
4. Transcription therapy for acute promyelocytic leukaemia.
Douer D
Expert Opin Investig Drugs; 2000 Feb; 9(2):329-46. PubMed ID: 11060680
[TBL] [Abstract][Full Text] [Related]
5. Retinoic Acid-Induced Gene G(RIG-G) as a Novel Monitoring Biomarker in Leukemia and Its Clinical Applications.
Wang F; Tian J; Pang L; Wu J; Shang A; Sun Z; Li D; Yan J; Quan W
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356051
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
7. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.
Tobal K; Moore H; Macheta M; Yin JA
Leukemia; 2001 Jul; 15(7):1060-5. PubMed ID: 11455974
[TBL] [Abstract][Full Text] [Related]
8. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia.
Hu L; Liu J; Meng Y; Zheng H; Ding C; Wang H; Charwudzi A; Li M; Li J; Zhai Z; Xiong S
RNA Biol; 2021 Oct; 18(10):1434-1444. PubMed ID: 33241756
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.
Gu BW; Hu J; Xu L; Yan H; Jin WR; Zhu YM; Zhao WL; Niu C; Cao Q; Su XY; Gu J; Ying HY; Chen Y; Xiong SM; Shen ZX; Chen Z; Chen SJ
Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells.
Zeng C; Xu Y; Xu L; Yu X; Cheng J; Yang L; Chen S; Li Y
BMC Cancer; 2014 Sep; 14():693. PubMed ID: 25245097
[TBL] [Abstract][Full Text] [Related]
12. Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARα transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients.
Barzegar M; Farsani MA; Rafiee M; Amiri V; Parkhihdeh S; Rad F; Mohammadi MH
Ann Hematol; 2021 Sep; 100(9):2241-2252. PubMed ID: 34236496
[TBL] [Abstract][Full Text] [Related]
13. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
14. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
[TBL] [Abstract][Full Text] [Related]
15. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
16. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report.
Pardo Gambarte L; Franganillo Suárez A; Cornago Navascués J; Soto de Ozaeta C; Blas López C; Atance Pasarisas M; Salgado Sánchez RN; Serrano Del Castillo C; Mata Serna R; Velasco Rodríguez D; López-Lorenzo JL; Llamas-Sillero P; Solán Blanco L
Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454359
[TBL] [Abstract][Full Text] [Related]
17. C/EBPα is indispensable for PML/RARα-mediated suppression of long non-coding RNA NEAT1 in acute promyelocytic leukemia cells.
Tang D; Hu P; Zhu D; Luo Y; Chen M; Zhang G; Wang Y
Aging (Albany NY); 2021 Apr; 13(9):13179-13194. PubMed ID: 33901013
[TBL] [Abstract][Full Text] [Related]
18. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
[TBL] [Abstract][Full Text] [Related]
19. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA.
Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP
Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
